Accessibility Menu
 
Goodbody Health logo

Goodbody Health

(OTC) GDBYF

Current Price$0.00
Market CapN/A
Since IPO (2020)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Goodbody Health Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$16.47M

Net Income (TTM)

$3.72M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-22.24 (Low)

Price

$0.00

Volume

1,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

GDBYF News

No articles available.

GDBYF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Goodbody Health

Industry

Pharmaceuticals

CEO

George Howard Prance Thomas

Headquarters

Vancouver, BC V6E 4N7, CA

GDBYF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-6%

Net Income Margin

-14%

Return on Equity

0%

Return on Capital

-15%

Return on Assets

-21%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

36.50M

Volume

1.50K

Short Interest

0.00%

Avg. Volume

0

Financials (TTM)

Gross Profit

$8.93M

Operating Income

$1.06M

EBITDA

$13.74K

Operating Cash Flow

$1.86M

Capital Expenditure

$253.65K

Free Cash Flow

$1.60M

Cash & ST Invst.

$6.07M

Total Debt

$336.95K

Goodbody Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$1.89M

-62.4%

Gross Profit

$846.71K

-68.4%

Gross Margin

44.89%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.27M

-68237.8%

EBITDA

$842.00K

-264.6%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Net Cash

$2.91M

-20.0%

Accounts Receivable

$194.29K

-50.0%

Inventory

$484.22K

-31.2%

Long Term Debt

$17.59K

-92.3%

Short Term Debt

$121.34K

-25.5%

Return on Assets

-21.34%

N/A

Return on Invested Capital

-14.57%

N/A

Free Cash Flow

$793.10K

-272.2%

Operating Cash Flow

$752.10K

-251.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACORQAcorda Therapeutics, Inc.
$0.01-24.81%
CHCRAdvanzeon Solutions, Inc.
$0.00+0.00%
GNBTGenerex Biotechnology Corporation
$0.00+0.00%
NWYUNew You, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About GDBYF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.